Business Context and Reporting Period
This Form 8-K filing by LabStyle Innovations Corp. (not Dariohealth Corp.) reports a corporate action effective February 26, 2016, with the report filed on March 3, 2016. The company is incorporated in Delaware and headquartered in Caesarea Industrial Park, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes.
Material Changes Versus Prior Period
- Reverse Stock Split: The company executed a 1-for-18 reverse stock split of its outstanding common stock.
- Share Count Reduction: Issued and outstanding shares decreased from approximately 53.5 million to approximately 3.0 million.
- Par Value: All shares maintain a par value of $0.0001.
- Authorized Shares: The total authorized share count of 160 million remained unaffected.
- Fractional Shares: Fractional shares resulting from the split were rounded up to the next whole number.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the execution of the stock split. The split was approved by the board of directors under authority granted by stockholders at the 2015 Annual Meeting.
Important Facts for Investor Verification
- Verify the post-split share count of approximately 3.0 million shares.
- Confirm the 1-for-18 split ratio and the rounding up of fractional shares.
- Review the attached Certificate of Amendment (Exhibit 3.1) filed with the Delaware Secretary of State on February 25, 2016.
- Note that the authorized share cap remains at 160 million shares.